Current status of bispecific antibodies and CAR-T therapies in multiple myeloma
-
Published:2024-06
Issue:
Volume:134
Page:112043
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Szlasa WojciechORCID,
Dybko Jarosław
Reference93 articles.
1. Multiple myeloma: a model for scientific and clinical progress;Miguel;Hematology,2014
2. Multiple myeloma: molecular pathogenesis and disease evolution;Heider;Oncol Res Treat,2021
3. Molecular aspects of multiple myeloma;Pratt;Mol. Pathol.,2002
4. Treatment of multiple myeloma;Barlogie;Blood,2004
5. B. E. Monteith, I. Sandhu, and A. S. Lee, “Management of Multiple Myeloma: A Review for General Practitioners in Oncology,” Current Oncology 2023, Vol. 30, Pages 4382-4401, vol. 30, no. 5, pp. 4382–4401, Apr. 2023, doi: 10.3390/CURRONCOL30050334.